Janux Therapeutics, Inc. (JANX) vs MannKind Corporation (MNKD)
Janux Therapeutics, Inc. and MannKind Corporation are both Biotechnology companies. Janux Therapeutics, Inc. and MannKind Corporation are of similar size ($1.1B and $1.0B). Janux Therapeutics, Inc. grew revenue faster over the last twelve months: 83.9% against 30.5%. MannKind Corporation has the higher net margin (−11.1% vs −427.5%) and the higher return on invested capital (2.36% vs 0.00%). Across the 16 metrics below, MannKind Corporation leads on 11 and Janux Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | JANX | MNKD | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 75.39% | 65.16% |
| Operating margin | (598.15%) | 2.34% | 0.00% |
| Net margin | (427.47%) | (11.08%) | 0.00% |
| Free cash flow margin | (174.69%) | (4.61%) | 0.00% |
| Return on equity | (10.70%) | 71.36% | (57.72%) |
| Return on assets | (10.06%) | (7.62%) | (49.22%) |
| Return on invested capital | 0.00% | 2.36% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack